Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmed Cina Caspian Pouyesh Company (also known as PharMedCina) is an Iranian pharmaceutical and biotechnology company based in Shiraz. The company specializes in the development and production of pharmaceutical products, with a primary focus on organ preservation and perfusion solutions used in transplantation. Its flagship product is a locally-produced Histidine-Tryptophan-Ketoglutarate (HTK) solution, which serves as an affordable and accessible alternative to imported preservation solutions like Custodiol® for liver and other organ transplantations. Pharmed Cina Caspian Pouyesh operates as a recognized knowledge-based (Danesh-Bonyan) enterprise and collaborates closely with the Shiraz University of Medical Sciences and the Shiraz Transplant Center.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmed Cina Caspian Pouyesh.